[Chronic lymphocytic leukemia of T-cells with a suppressor phenotype (T3+, T4-, T8+). Report of 2 cases]. 1984

M T Calabuig, and J Outeiriño, and A Escudero, and M E Prieto, and M G Pérez-Rus, and M I Pérez Sánchez, and M M Méndez, and J Sánchez-Fayos

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008232 Lymphoproliferative Disorders Disorders characterized by proliferation of lymphoid tissue, general or unspecified. Duncan's Syndrome,X-Linked Lymphoproliferative Syndrome,Duncan Disease,Epstein-Barr Virus Infection, Familial Fatal,Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males,Familial Fatal Epstein-Barr Infection,Immunodeficiency 5,Immunodeficiency, X-Linked Progressive Combined Variable,Lymphoproliferative Disease, X-Linked,Lymphoproliferative Syndrome, X-Linked, 1,Purtilo Syndrome,X-Linked Lymphoproliferative Disease,X-Linked Lymphoproliferative Disorder,Disease, Duncan,Disease, X-Linked Lymphoproliferative,Diseases, X-Linked Lymphoproliferative,Disorder, Lymphoproliferative,Disorder, X-Linked Lymphoproliferative,Disorders, Lymphoproliferative,Disorders, X-Linked Lymphoproliferative,Epstein Barr Virus Induced Lymphoproliferative Disease In Males,Epstein Barr Virus Infection, Familial Fatal,Familial Fatal Epstein Barr Infection,Immunodeficiency 5s,Immunodeficiency, X Linked Progressive Combined Variable,Lymphoproliferative Disease, X Linked,Lymphoproliferative Diseases, X-Linked,Lymphoproliferative Disorder,Lymphoproliferative Disorder, X-Linked,Lymphoproliferative Disorders, X-Linked,Lymphoproliferative Syndrome, X-Linked,Lymphoproliferative Syndromes, X-Linked,Purtilo Syndromes,Syndrome, Purtilo,Syndrome, X-Linked Lymphoproliferative,Syndromes, Purtilo,Syndromes, X-Linked Lymphoproliferative,X Linked Lymphoproliferative Disease,X Linked Lymphoproliferative Disorder,X Linked Lymphoproliferative Syndrome,X-Linked Lymphoproliferative Diseases,X-Linked Lymphoproliferative Disorders,X-Linked Lymphoproliferative Syndromes
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000912 Antibodies, Neoplasm Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS. Neoplasm Antibodies,Tumor Antibodies,Antibodies, Tumor
D012751 Sezary Syndrome A form of cutaneous T-cell lymphoma manifested by generalized exfoliative ERYTHRODERMA; PRURITUS; peripheral lymphadenopathy, and abnormal hyperchromatic mononuclear (cerebriform) cells in the skin, LYMPH NODES, and peripheral blood (Sezary cells). Erythroderma, Sezary,Sezary's Lymphoma,Lymphoma, Sezary's,Sezary Erythroderma,Sezary Lymphoma,Sezarys Lymphoma,Syndrome, Sezary

Related Publications

M T Calabuig, and J Outeiriño, and A Escudero, and M E Prieto, and M G Pérez-Rus, and M I Pérez Sánchez, and M M Méndez, and J Sánchez-Fayos
June 1988, Blood,
M T Calabuig, and J Outeiriño, and A Escudero, and M E Prieto, and M G Pérez-Rus, and M I Pérez Sánchez, and M M Méndez, and J Sánchez-Fayos
June 1986, Australian and New Zealand journal of medicine,
M T Calabuig, and J Outeiriño, and A Escudero, and M E Prieto, and M G Pérez-Rus, and M I Pérez Sánchez, and M M Méndez, and J Sánchez-Fayos
January 1984, Nature,
M T Calabuig, and J Outeiriño, and A Escudero, and M E Prieto, and M G Pérez-Rus, and M I Pérez Sánchez, and M M Méndez, and J Sánchez-Fayos
August 1982, Clinical and experimental immunology,
M T Calabuig, and J Outeiriño, and A Escudero, and M E Prieto, and M G Pérez-Rus, and M I Pérez Sánchez, and M M Méndez, and J Sánchez-Fayos
January 1988, Journal of biological regulators and homeostatic agents,
M T Calabuig, and J Outeiriño, and A Escudero, and M E Prieto, and M G Pérez-Rus, and M I Pérez Sánchez, and M M Méndez, and J Sánchez-Fayos
January 1989, Anticancer research,
M T Calabuig, and J Outeiriño, and A Escudero, and M E Prieto, and M G Pérez-Rus, and M I Pérez Sánchez, and M M Méndez, and J Sánchez-Fayos
November 1983, Mayo Clinic proceedings,
M T Calabuig, and J Outeiriño, and A Escudero, and M E Prieto, and M G Pérez-Rus, and M I Pérez Sánchez, and M M Méndez, and J Sánchez-Fayos
January 1988, Medical and pediatric oncology,
M T Calabuig, and J Outeiriño, and A Escudero, and M E Prieto, and M G Pérez-Rus, and M I Pérez Sánchez, and M M Méndez, and J Sánchez-Fayos
September 1983, American journal of clinical pathology,
M T Calabuig, and J Outeiriño, and A Escudero, and M E Prieto, and M G Pérez-Rus, and M I Pérez Sánchez, and M M Méndez, and J Sánchez-Fayos
April 1987, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!